2026 QIC CEO Week
Date: 2026/4/14 ~ 15 Tue. to Wed., Location: The Fullerton Hotel Singapore
Conference Information: Quantum International Corp. - 19th QIC CEO WEEK
Trust Bio-sonics at the 19th QIC CEO Week
Trust Bio-sonics is pleased to announce its participation in the 19th QIC CEO Week in Singapore. We look forward to engaging with international investors to share our core strengths and strategic vision for the future of precision medicine.
About Trust Bio-sonics
Trust Bio-sonics is a global leader in the development of Lipid Microsphere technology. We are dedicated to integrating advanced medical imaging diagnostics with innovative drug delivery systems, providing comprehensive precision medicine solutions for cardiovascular diseases and oncology.
Core Technology & Strategic Advantages
Proprietary Lipid Microsphere Platform: Our self-developed platform produces highly stable, small-diameter microbubble formulations with exceptional biocompatibility.
Next-Generation Ultrasound Diagnostics: Our flagship product, TBS-002, significantly enhances micro-blood flow imaging to assist in the early diagnosis of cancer and cardiovascular conditions. Currently in Phase 3 clinical trials in both Taiwan and the U.S., TBS-002 demonstrates immense commercial potential.
Precision Drug Delivery (Therapy): Our exclusive Ultrasound Drug Delivery System (UDDS) leverages microbubble cavitation for the precise, non-invasive delivery of therapeutics directly to lesions. This approach minimizes systemic side effects while maximizing efficacy. The program is currently in Phase 1 clinical trials in Taiwan.
Through our participation in QIC CEO Week, Trust Bio-sonics aims to connect with the global capital markets to accelerate the international deployment of our ultrasound-based precision medicine and fulfill our mission of "Early Diagnosis, Precise Treatment."
Reserve your spot today. For inquiries regarding the QIC CEO Week, please contact Yvonne Huang at yvonnehuang@qtumic.com for more information.